- Home
- NTWK vs RVPH Comparison
NTWK vs RVPH Comparison
Compare NTWK & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- RVPH
- Stock Information
- Founded
- NTWK 1997
- RVPH 2006
- Country
- NTWK United States
- RVPH United States
- Employees
- NTWK N/A
- RVPH N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- NTWK Technology
- RVPH Health Care
- Exchange
- NTWK Nasdaq
- RVPH Nasdaq
- Market Cap
- NTWK 31.1M
- RVPH 33.4M
- IPO Year
- NTWK 1998
- RVPH N/A
- Fundamental
- Price
- NTWK $2.69
- RVPH $1.13
- Analyst Decision
- NTWK
- RVPH Strong Buy
- Analyst Count
- NTWK 0
- RVPH 4
- Target Price
- NTWK N/A
- RVPH $15.33
- AVG Volume (30 Days)
- NTWK 21.9K
- RVPH 697.8K
- Earning Date
- NTWK 11-13-2024
- RVPH 11-26-2024
- Dividend Yield
- NTWK N/A
- RVPH N/A
- EPS Growth
- NTWK N/A
- RVPH N/A
- EPS
- NTWK 0.06
- RVPH N/A
- Revenue
- NTWK $61,749,408.00
- RVPH N/A
- Revenue This Year
- NTWK N/A
- RVPH N/A
- Revenue Next Year
- NTWK N/A
- RVPH N/A
- P/E Ratio
- NTWK $42.79
- RVPH N/A
- Revenue Growth
- NTWK 14.50
- RVPH N/A
- 52 Week Low
- NTWK $1.94
- RVPH $0.60
- 52 Week High
- NTWK $3.34
- RVPH $5.67
- Technical
- Relative Strength Index (RSI)
- NTWK 35.05
- RVPH 49.00
- Support Level
- NTWK $2.95
- RVPH $0.88
- Resistance Level
- NTWK $3.23
- RVPH $1.45
- Average True Range (ATR)
- NTWK 0.16
- RVPH 0.14
- MACD
- NTWK -0.04
- RVPH 0.02
- Stochastic Oscillator
- NTWK 11.48
- RVPH 42.98
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.